M. G. Finazzi

Combination Antifungal Therapy for Invasive Aspergillosis

R. Barbó, L. Barozzi, D. Ripamonti, 2005 .

Reply to Nucci and Anaissie

R. Barbó, D. Ripamonti, F. Suter, 2005 .

Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.

A. d’Arminio Monforte, A. Antinori, P. Cinque, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution

F. Maggiolo, D. Ripamonti, F. Suter, 2001, International journal of STD & AIDS.

New times for an old disease: intracranial mass lesions caused by Mycobacterium tuberculosis in 5 HIV-negative African immigrants.

R. Barbó, D. Ripamonti, F. Suter, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with the failure of HIV-positive persons to return for scheduled medical visits

P. Pezzotti, F. Maggiolo, D. Ripamonti, 2002, HIV clinical trials.

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

A. Antinori, P. Cinque, P. Lorenzini, 2011, Journal of NeuroVirology.

[Tuberculosis in Bergamo Province. Statistical estimates for the quadrennium 1984-1987].

A. Minio, L. Maggi, A. Grigis, 1990, Minerva medica.

Discordant immunological response in HIV-positive patients on non-nucleoside reverse transcriptase inhibitor-based regimens.

F. Maggiolo, D. Ripamonti, F. Suter, 2002, AIDS (London).